Circassia Group Plc (CIR) is a leading biotechnology business based in the UK. It opened the day at 28.4p after a previous close of 27.9p. During the day the price has varied from a low of 27.35p to a high of 28.55p. The latest price was 27.55p (25 minute delay). Circassia Group is listed on the London Stock Exchange (LSE) and employs 350 staff. All prices are listed in pence sterling.
Since the stock market crash in March caused by coronavirus, Circassia Group's share price has had significant negative movement.
Its last market close was 25.175p, which is 2.42% down on its pre-crash value of 25.8p and 101.40% up on the lowest point reached during the March crash when the shares fell as low as 12.5p.
If you had bought £1,000 worth of Circassia Group shares at the start of February 2020, those shares would have been worth £459.96 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £895.91.
|52-week range||12.5p - 33.4025p|
|50-day moving average||27.1456p|
|200-day moving average||26.3944p|
|Wall St. target price||99p|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||-33.7p|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 week (2021-01-14)||5.35%|
|1 month (2020-12-22)||3.28%|
|3 months (2020-10-22)||16.86%|
|6 months (2020-07-22)||0.73%|
|1 year (2020-01-22)||7.62%|
|2 years (2019-01-21)||-44.79%|
|3 years (2018-01-19)||-70.25%|
|5 years (2016-01-21)||-90.23%|
|Revenue TTM||£55.2 million|
|Gross profit TTM||£46.2 million|
|Return on assets TTM||-12.43%|
|Return on equity TTM||-56.35%|
|Market capitalisation||£105 million|
TTM: trailing 12 months
We're not expecting Circassia Group to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Over the last 12 months, Circassia Group's shares have ranged in value from as little as 12.5p up to 33.4025p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Circassia Group's is 1.8248. This would suggest that Circassia Group's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Circassia Group Plc, a specialty pharmaceutical company, focuses on the development and commercialization of respiratory products. It operates through three segments: NIOX, Chronic Obstructive Pulmonary Disease (COPD), and LungFit. The company markets NIOX and NIOX VERO for use in asthma diagnosis and management; Tudorza for the treatment of COPD; and Duaklir, a fixed-dose combination of the long-acting muscarinic antagonist aclidinium bromide and long-acting beta agonist formoterol fumarate, which is administered twice-daily through the breath actuated Pressair inhaler for the maintenance treatment of COPD. It is also developing LungFit, a portable ventilator-compatible system that utilizes an electric voltage to produce precise quantities of nitric oxide from the nitrogen and oxygen in air. The company markets its products directly to specialists in the United States, the United Kingdom, China, Italy, and Germany, as well as through a network of partners internationally. Circassia Group Plc has a collaboration agreement with AstraZeneca to promote Tudorza and Duaklir for COPD treatment; and the United States and Chinese commercial rights to LungFit. The company was formerly known as Circassia Pharmaceuticals plc and changed its name to Circassia Group Plc in May 2020. Circassia Group Plc was founded in 2006 and is headquartered in Oxford, the United Kingdom.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.